alpha-hydroxyglutarate has been researched along with Glioblastoma in 16 studies
2-hydroxyglutarate : A dicarboxylic acid anion obtained by deprotonation of at least one of the carboxy groups of 2-hydroxyglutaric acid.
2-hydroxyglutaric acid : A 2-hydroxydicarboxylic acid that is glutaric acid in which one hydrogen alpha- to a carboxylic acid group is substituted by a hydroxy group.
Glioblastoma: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.
Excerpt | Relevance | Reference |
---|---|---|
"Previous ex vivo spectroscopic data from tissue samples revealed differences in phospholipid metabolites between isocitrate dehydrogenase mutated (IDHmut) and IDH wildtype (IDHwt) gliomas." | 3.91 | In vivo Metabolic Profiles as Determined by ( Bähr, O; Franz, K; Hattingen, E; Pilatus, U; Steinbach, J; Wenger, KJ, 2019) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (6.25) | 29.6817 |
2010's | 12 (75.00) | 24.3611 |
2020's | 3 (18.75) | 2.80 |
Authors | Studies |
---|---|
Walsby-Tickle, J | 1 |
Gannon, J | 1 |
Hvinden, I | 1 |
Bardella, C | 1 |
Abboud, MI | 1 |
Nazeer, A | 1 |
Hauton, D | 1 |
Pires, E | 1 |
Cadoux-Hudson, T | 1 |
Schofield, CJ | 1 |
McCullagh, JSO | 1 |
Barekatain, Y | 1 |
Yan, VC | 1 |
Arthur, K | 1 |
Ackroyd, JJ | 1 |
Khadka, S | 1 |
De Groot, J | 1 |
Huse, JT | 1 |
Muller, FL | 1 |
Bhandari, A | 1 |
Sharma, C | 1 |
Ibrahim, M | 1 |
Riggs, M | 1 |
Jones, R | 1 |
Lasocki, A | 1 |
Natsumeda, M | 1 |
Motohashi, K | 1 |
Igarashi, H | 1 |
Nozawa, T | 1 |
Abe, H | 1 |
Tsukamoto, Y | 1 |
Ogura, R | 1 |
Okada, M | 1 |
Kobayashi, T | 1 |
Aoki, H | 1 |
Takahashi, H | 1 |
Kakita, A | 1 |
Okamoto, K | 1 |
Nakada, T | 1 |
Fujii, Y | 1 |
Wenger, KJ | 1 |
Hattingen, E | 1 |
Franz, K | 1 |
Steinbach, J | 1 |
Bähr, O | 1 |
Pilatus, U | 1 |
Karpel-Massler, G | 1 |
Ishida, CT | 1 |
Bianchetti, E | 1 |
Zhang, Y | 2 |
Shu, C | 1 |
Tsujiuchi, T | 1 |
Banu, MA | 1 |
Garcia, F | 1 |
Roth, KA | 1 |
Bruce, JN | 1 |
Canoll, P | 1 |
Siegelin, MD | 1 |
Miyata, S | 1 |
Tominaga, K | 1 |
Sakashita, E | 1 |
Urabe, M | 1 |
Onuki, Y | 1 |
Gomi, A | 1 |
Yamaguchi, T | 1 |
Mieno, M | 1 |
Mizukami, H | 1 |
Kume, A | 1 |
Ozawa, K | 1 |
Watanabe, E | 1 |
Kawai, K | 1 |
Endo, H | 1 |
Izquierdo-Garcia, JL | 1 |
Viswanath, P | 1 |
Eriksson, P | 1 |
Cai, L | 1 |
Radoul, M | 1 |
Chaumeil, MM | 1 |
Blough, M | 1 |
Luchman, HA | 1 |
Weiss, S | 1 |
Cairncross, JG | 1 |
Phillips, JJ | 1 |
Pieper, RO | 1 |
Ronen, SM | 1 |
Waitkus, MS | 1 |
Diplas, BH | 1 |
Yan, H | 3 |
Fu, X | 1 |
Chin, RM | 1 |
Vergnes, L | 1 |
Hwang, H | 1 |
Deng, G | 2 |
Xing, Y | 1 |
Pai, MY | 1 |
Li, S | 1 |
Ta, L | 1 |
Fazlollahi, F | 1 |
Chen, C | 1 |
Prins, RM | 1 |
Teitell, MA | 1 |
Nathanson, DA | 1 |
Lai, A | 1 |
Faull, KF | 1 |
Jiang, M | 1 |
Clarke, SG | 1 |
Cloughesy, TF | 1 |
Graeber, TG | 1 |
Braas, D | 1 |
Christofk, HR | 1 |
Jung, ME | 1 |
Reue, K | 1 |
Huang, J | 1 |
Tateishi, K | 1 |
Wakimoto, H | 1 |
Iafrate, AJ | 1 |
Tanaka, S | 1 |
Loebel, F | 1 |
Lelic, N | 1 |
Wiederschain, D | 1 |
Bedel, O | 1 |
Zhang, B | 1 |
He, T | 1 |
Shi, X | 1 |
Gerszten, RE | 1 |
Yeh, JJ | 1 |
Curry, WT | 1 |
Zhao, D | 1 |
Sundaram, S | 1 |
Nigim, F | 1 |
Koerner, MVA | 1 |
Ho, Q | 1 |
Fisher, DE | 1 |
Roider, EM | 1 |
Kemeny, LV | 1 |
Samuels, Y | 1 |
Flaherty, KT | 1 |
Batchelor, TT | 1 |
Chi, AS | 1 |
Cahill, DP | 1 |
Giampà, M | 1 |
Lissel, MB | 1 |
Patschkowski, T | 1 |
Fuchser, J | 1 |
Hans, VH | 1 |
Gembruch, O | 1 |
Bednarz, H | 1 |
Niehaus, K | 1 |
Reitman, ZJ | 2 |
Garber, K | 1 |
Jin, G | 1 |
Duncan, CG | 1 |
Spasojevic, I | 1 |
Gooden, DM | 1 |
Rasheed, BA | 1 |
Yang, R | 1 |
Lopez, GY | 1 |
He, Y | 1 |
McLendon, RE | 1 |
Bigner, DD | 1 |
Moroni, I | 1 |
Bugiani, M | 1 |
D'Incerti, L | 1 |
Maccagnano, C | 1 |
Rimoldi, M | 1 |
Bissola, L | 1 |
Pollo, B | 1 |
Finocchiaro, G | 1 |
Uziel, G | 1 |
4 reviews available for alpha-hydroxyglutarate and Glioblastoma
Article | Year |
---|---|
The role of 2-hydroxyglutarate magnetic resonance spectroscopy for the determination of isocitrate dehydrogenase status in lower grade gliomas versus glioblastoma: a systematic review and meta-analysis of diagnostic test accuracy.
Topics: Brain Neoplasms; Diagnostic Tests, Routine; Glioblastoma; Glioma; Glutarates; Humans; Isocitrate Deh | 2021 |
Isocitrate dehydrogenase mutations in gliomas.
Topics: Animals; Brain Neoplasms; Glioblastoma; Glioma; Glutarates; Humans; Isocitrate Dehydrogenase; Ketogl | 2016 |
Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism.
Topics: Animals; Arginine; Brain Neoplasms; Codon; Gene Expression Regulation, Enzymologic; Gene Expression | 2010 |
L-2-hydroxyglutaric aciduria and brain malignant tumors: a predisposing condition?
Topics: Adolescent; Adult; Astrocytoma; Brain Diseases, Metabolic; Brain Neoplasms; Cerebellar Ataxia; Child | 2004 |
12 other studies available for alpha-hydroxyglutarate and Glioblastoma
Article | Year |
---|---|
Anion-exchange chromatography mass spectrometry provides extensive coverage of primary metabolic pathways revealing altered metabolism in IDH1 mutant cells.
Topics: Cell Line, Tumor; Chromatography, Ion Exchange; Glioblastoma; Glutarates; Humans; Isocitrate Dehydro | 2020 |
Robust detection of oncometabolic aberrations by
Topics: Animals; Biomarkers, Tumor; Carbon Isotopes; Cell Line, Tumor; Female; Glioblastoma; Gluconates; Glu | 2020 |
Reliable diagnosis of IDH-mutant glioblastoma by 2-hydroxyglutarate detection: a study by 3-T magnetic resonance spectroscopy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Neoplasms; Child; Female; Glioblastoma; Glutarates | 2018 |
In vivo Metabolic Profiles as Determined by
Topics: Adult; Aged; Analysis of Variance; Astrocytoma; Biomarkers, Tumor; Brain Neoplasms; Diagnosis, Diffe | 2019 |
Induction of synthetic lethality in IDH1-mutated gliomas through inhibition of Bcl-xL.
Topics: Aniline Compounds; Animals; Antineoplastic Agents; Apoptosis; Astrocytoma; bcl-X Protein; Brain Neop | 2017 |
Comprehensive Metabolomic Analysis of IDH1
Topics: Adult; Aged; Biomarkers, Tumor; Brain Neoplasms; Carnitine; Cell Division; Cell Line, Tumor; Female; | 2019 |
IDH1 Mutation Induces Reprogramming of Pyruvate Metabolism.
Topics: Astrocytes; Cell Line, Tumor; Cell Proliferation; Dichloroacetic Acid; Down-Regulation; Glioblastoma | 2015 |
2-Hydroxyglutarate Inhibits ATP Synthase and mTOR Signaling.
Topics: Adenosine Triphosphatases; Animals; Caenorhabditis elegans; Cell Proliferation; Glioblastoma; Glutar | 2015 |
Extreme Vulnerability of IDH1 Mutant Cancers to NAD+ Depletion.
Topics: AMP-Activated Protein Kinases; Animals; Antineoplastic Agents; Autophagy; Brain Neoplasms; Cell Prol | 2015 |
Maleic anhydride proton sponge as a novel MALDI matrix for the visualization of small molecules (<250 m/z) in brain tumors by routine MALDI ToF imaging mass spectrometry.
Topics: Brain; Brain Neoplasms; Chlorides; Glioblastoma; Glutarates; Humans; Lactic Acid; Maleic Anhydrides; | 2016 |
Oncometabolite? IDH1 discoveries raise possibility of new metabolism targets in brain cancers and leukemia.
Topics: Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppre | 2010 |
Disruption of wild-type IDH1 suppresses D-2-hydroxyglutarate production in IDH1-mutated gliomas.
Topics: Astrocytoma; Brain Neoplasms; Cell Line, Tumor; Genotype; Glioblastoma; Glioma; Glutarates; Humans; | 2013 |